The effects of canagliflozin compared to sitagliptin on cardiorespiratory fitness in type 2 diabetes mellitus and heart failure with reduced ejection fraction: The CANA‐HF study

BACKGROUND: Canagliflozin reduces hospitalizations for heart failure (HF) in type 2 diabetes mellitus (T2DM). Its effect on cardiorespiratory fitness and cardiac function in patients with established HF with reduced ejection fraction (HFrEF) is unknown. METHODS: We conducted a double‐blind randomize...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Diabetes Metab Res Rev
Main Authors: Carbone, Salvatore, Billingsley, Hayley E., Canada, Justin M., Bressi, Edoardo, Rotelli, Brando, Kadariya, Dinesh, Dixon, Dave L., Markley, Roshanak, Trankle, Cory R., Cooke, Richard, Rao, Krishnasree, B. Shah, Keyur, Medina de Chazal, Horacio, Chiabrando, Juan Guido, Vecchié, Alessandra, Dell, Megan, L. Mihalick, Virginia, Bogaev, Roberta, Hart, Linda, Van Tassell, Benjamin W., Arena, Ross, Celi, Francesco S., Abbate, Antonio
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons, Inc. 2020
Assuntos:
Research Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7685099/
https://ncbi.nlm.nih.gov/pubmed/32415802
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/dmrr.3335
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados